🟢 Neurosense Therapeutics is trading 5.4% up today with no confirmed company-specific catalyst

Neurosense Therapeutics is trading 5.4% up at $0.50, possibly reflecting broader risk-on sentiment, though the catalyst remains unconfirmed.

• No fresh company-specific announcement on August 12, 2026 clearly explains the move.
• Recent coverage references the August 6 Health Canada filing update and the August 26 reverse-split shareholder vote.
• U.S. equities are modestly higher, including the Nasdaq Composite at 0.52%.